Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000055

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 4, 2017
Accepted (ET)
May 8, 2017 · 3:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 4, 2017P1,000$0.068A20,629,949D
Common StockMay 4, 2017P1,000$0.07A20,630,949D
Common StockMay 4, 2017P1,000$0.07A20,631,949D
Common StockMay 4, 2017P1,000$0.07A20,632,949D
Common StockMay 4, 2017P1,000$0.07A20,633,949D
Common StockMay 4, 2017P1,000$0.07A20,634,949D
Common StockMay 4, 2017P1,000$0.0699A20,635,949D
Common StockMay 4, 2017P1,000$0.0699A20,636,949D
Common StockMay 4, 2017P1,000$0.0695A20,637,949D
Common StockMay 4, 2017P1,000$0.08A20,638,949D
Common StockMay 4, 2017P1,000$0.081A20,639,949D
Common StockMay 4, 2017P1,000$0.082A20,640,949D
Common StockMay 4, 2017P1,000$0.082A20,641,949D
Common StockMay 4, 2017P1,000$0.083A20,642,949D
Common StockMay 4, 2017P1,000$0.0819A20,643,949D
Common StockMay 4, 2017P1,000$0.0819A20,644,949D
Common StockMay 4, 2017P1,000$0.0796A20,645,949D
Common StockMay 4, 2017P1,000$0.078A20,646,949D
Common StockMay 4, 2017P1,000$0.078A20,647,949D
Common StockMay 4, 2017P1,000$0.0798A20,648,949D
Common StockMay 4, 2017P1,000$0.0729A20,649,949D
Common StockMay 4, 2017P1,000$0.075A20,650,949D
Common StockMay 4, 2017P1,000$0.0745A20,651,949D

Table II — derivative securities

No Table II lines on this filing.